Investment Announcement from Datavault AI Inc.
Datavault AI Inc. (NASDAQ: DVLT), renowned for its innovative approach in AI-driven data visualization and monetization, recently announced the closure of the first tranche of an impressive $150 million Bitcoin investment sourced from Scilex Holding Company (NASDAQ: SCLX). This strategic investment marks a significant achievement for Datavault AI, as it solidifies its position in the rapidly evolving AI landscape.
Details of the Investment
Under the agreed terms, Scilex will acquire up to 278,914,094 shares of Datavault common stock at an effective price of $0.5378 per share, a figure that remains adjustable for stock splits and similar scenarios. Upon closing the initial tranche, Scilex has received 15,000,000 shares of Datavault. The remaining portion will be allocated in a second tranche, with the issuance of a pre-funded warrant contingent upon stockholder approval to exceed 19.99% of Datavault’s outstanding shares prior to financing.
Understanding Datavault AI Inc.
Datavault AI is pioneering in the realm of AI-driven data applications, enhancing the valuation and monetization of various assets. Their cloud-based platform integrates expansive solutions across diverse sectors, prominently aided by their innovative Acoustic Science and Data Science Divisions. The Acoustic Science Division boasts patented technologies such as WiSA®, ADIO®, and Sumerian®, revolutionizing audio transmission and enhancing sound experiences through multichannel wireless capabilities. Meanwhile, the Data Science Division harnesses high-performance computing to redefine how data is perceived and monetized securely.
Industry Impact and Applications
Datavault AI's extensive technology suite is tailored for various industries, including sports and entertainment, education, healthcare, and fintech, showcasing adaptability. Notably, the Information Data Exchange® (IDE) promotes Digital Twins, effectively linking real-world assets to immutable metadata. This integration fosters the development of responsible AI practices while advancing industry innovations. Their offerings also include AI and machine learning automation, comprehensive analytics, and data-driven marketing automation.
Technological Innovations
The company is committed to offering customizable solutions that align with client needs, encompassing marketing automation and advertising monitoring capabilities. Their continuous innovation ensures that clients can navigate the data landscape efficiently, taking advantage of cutting-edge technologies to propel their brands forward.
Overview of Scilex Holding Company
Scilex is at the forefront of developing non-opioid pain management solutions aimed at addressing acute and chronic pain, as well as neurodegenerative diseases. Their mission revolves around improving patient outcomes by targeting high unmet needs through innovative therapies. Noteworthy commercial products include ZTlido®, an FDA-approved lidocaine topical solution, ELYXYB®, a ready-to-use oral solution for migraines, and Gloperba®, an anti-gout medication that stands out for its liquid formulation.
Future Prospects and Product Pipeline
Furthermore, Scilex is actively developing three promising product candidates, including SP-102, designed for treating radicular pain, and SP-104, aimed at fibromyalgia treatment. These developments underscore Scilex's unwavering commitment to advancing healthcare solutions that significantly improve quality of life.
Contact Information
For investors seeking more information about Datavault AI, they can reach out to the Alliance Advisors Investor Relations team at datavaultinvestors@allianceadvisors.com. Meanwhile, inquiries related to marketing can be directed to marketing@vault.email.
Frequently Asked Questions
What is Datavault AI Inc. known for?
Datavault AI Inc. is recognized for its advancements in AI-driven data visualization, valuation, and monetization technologies.
Who is investing in Datavault AI?
Scilex Holding Company is the entity behind the substantial $150 million investment into Datavault AI Inc.
How many shares are involved in the investment?
Scilex is set to receive up to 278,914,094 shares of Datavault common stock as part of the investment agreement.
What types of technologies does Datavault AI offer?
Datavault AI provides a suite of technologies focused on acoustic science, data perception, secure monetization, and AI/machine learning automation.
What are Scilex’s main areas of focus?
Scilex concentrates on developing non-opioid pain management products, targeting acute and chronic pain management solutions.
